Ga offline met de app Player FM !
#128 Developing a unique patented method of producing pharmaceutical-grade, rare cannabinoids with Dennis O’Neill
Gearchiveerde serie ("Inactieve feed" status)
When? This feed was archived on February 27, 2024 06:27 (). Last successful fetch was on November 16, 2023 22:13 ()
Why? Inactieve feed status. Onze servers konden geen geldige podcast feed ononderbroken ophalen.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 302435976 series 2817023
Dennis O’Neill is the President of BioMediCan, a biotech startup company that has developed a unique patented method of producing pharmaceutical-grade, 100% organic, non-GMO rare cannabinoids, including CBG, CBGA, THCV, THCVA, CBN, CBNA and high-value compounds using a proprietary organic biosynthesis platform at 70-90% lower cost than conventional methods.
The Cannabinoids 'CBD" Market is experiencing astronomical grow rates expecting the market to be $146 billion by 2026. There are over 200 known Cannabinoids many that are significantly more effective for treating multiple medical conditions than CBD's. The problem is it takes a significant amount of time to produce, is very expensive and there is a limited amounts that can be produced. BioMediCan has developed a bio-synthesized process where they can produce significant quantities that are free from Pesticide's/Contaminants"safer" at a fraction of the cost. We believe that this creates a significant opportunity to develop and sell mass quantities of these rare cannabinoids that are free of THC to the Global Market. BioMedican has a world-class scientific management team and 4 patents pending
Highlights
- How BioMediCan was founded and it’s unique value proposition
- Producing high-quality, low-cost non-THC products that circumvent FDA regulations
- Producing rare cannabinoids
- Health benefits of CBG, THCV, CBN
Links of Interest
- Biomedican https://biomedican.com/
- Dennis O’Neill on LinkedIn https://www.linkedin.com/in/oneillcapital/
- CBG and THCV: Beneficial Cannabinoids https://www.cbdschool.com/cbg-thcv-cannabinoids/
128 afleveringen
Gearchiveerde serie ("Inactieve feed" status)
When? This feed was archived on February 27, 2024 06:27 (). Last successful fetch was on November 16, 2023 22:13 ()
Why? Inactieve feed status. Onze servers konden geen geldige podcast feed ononderbroken ophalen.
What now? You might be able to find a more up-to-date version using the search function. This series will no longer be checked for updates. If you believe this to be in error, please check if the publisher's feed link below is valid and contact support to request the feed be restored or if you have any other concerns about this.
Manage episode 302435976 series 2817023
Dennis O’Neill is the President of BioMediCan, a biotech startup company that has developed a unique patented method of producing pharmaceutical-grade, 100% organic, non-GMO rare cannabinoids, including CBG, CBGA, THCV, THCVA, CBN, CBNA and high-value compounds using a proprietary organic biosynthesis platform at 70-90% lower cost than conventional methods.
The Cannabinoids 'CBD" Market is experiencing astronomical grow rates expecting the market to be $146 billion by 2026. There are over 200 known Cannabinoids many that are significantly more effective for treating multiple medical conditions than CBD's. The problem is it takes a significant amount of time to produce, is very expensive and there is a limited amounts that can be produced. BioMediCan has developed a bio-synthesized process where they can produce significant quantities that are free from Pesticide's/Contaminants"safer" at a fraction of the cost. We believe that this creates a significant opportunity to develop and sell mass quantities of these rare cannabinoids that are free of THC to the Global Market. BioMedican has a world-class scientific management team and 4 patents pending
Highlights
- How BioMediCan was founded and it’s unique value proposition
- Producing high-quality, low-cost non-THC products that circumvent FDA regulations
- Producing rare cannabinoids
- Health benefits of CBG, THCV, CBN
Links of Interest
- Biomedican https://biomedican.com/
- Dennis O’Neill on LinkedIn https://www.linkedin.com/in/oneillcapital/
- CBG and THCV: Beneficial Cannabinoids https://www.cbdschool.com/cbg-thcv-cannabinoids/
128 afleveringen
Alle afleveringen
×Welkom op Player FM!
Player FM scant het web op podcasts van hoge kwaliteit waarvan u nu kunt genieten. Het is de beste podcast-app en werkt op Android, iPhone en internet. Aanmelden om abonnementen op verschillende apparaten te synchroniseren.